Intracorporeal LVAD implantation in pediatric patients: A single-center 10 years' experience.
HVAD
Heartmate
LVAD
children
end stage heart failure
pediatric
transplant
Journal
Artificial organs
ISSN: 1525-1594
Titre abrégé: Artif Organs
Pays: United States
ID NLM: 7802778
Informations de publication
Date de publication:
21 Feb 2024
21 Feb 2024
Historique:
revised:
28
11
2023
received:
04
09
2023
accepted:
08
01
2024
medline:
21
2
2024
pubmed:
21
2
2024
entrez:
21
2
2024
Statut:
aheadofprint
Résumé
Mechanical cardiac support is currently an effective strategy to reduce morbidity and mortality in pediatric patients. However, solid evidence regarding the feasibility of intracorporeal devices in children still needs to be provided. We report our 10-year experience with intracorporeal left ventricular assist devices (LVAD) in children. We included all patients undergoing intracorporeal, continuous-flow LVAD implantation between 2012 and 2022. Baseline and postoperative data were collected from the institutional database. Seven HeartWare and 4 HeartMate3 were implanted in 11 patients (median age 13.9 years, median body surface area - BSA - 1.42 m Intracorporeal LVAD implantation proved to be a potentially feasible and safe option in young teenagers and children whose BSA was >1.0 m
Sections du résumé
BACKGROUND
BACKGROUND
Mechanical cardiac support is currently an effective strategy to reduce morbidity and mortality in pediatric patients. However, solid evidence regarding the feasibility of intracorporeal devices in children still needs to be provided. We report our 10-year experience with intracorporeal left ventricular assist devices (LVAD) in children.
MATERIALS AND METHODS
METHODS
We included all patients undergoing intracorporeal, continuous-flow LVAD implantation between 2012 and 2022. Baseline and postoperative data were collected from the institutional database.
RESULTS
RESULTS
Seven HeartWare and 4 HeartMate3 were implanted in 11 patients (median age 13.9 years, median body surface area - BSA - 1.42 m
CONCLUSIONS
CONCLUSIONS
Intracorporeal LVAD implantation proved to be a potentially feasible and safe option in young teenagers and children whose BSA was >1.0 m
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
Références
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022;75(6):523.
Almond CSD, Thiagarajan RR, Piercey GE, Gauvreau K, Blume ED, Bastardi HJ, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119(5):717-727.
Rossano JW, VanderPluym CJ, Peng DM, Hollander SA, Maeda K, Adachi I, et al. Fifth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report. Ann Thorac Surg. 2021;112(6):1763-1774.
Foster G. Chapter 5 - Third-generation ventricular assist devices. In: Gregory SD, Stevens MC, Fraser JF, editors. Mechanical circulatory and respiratory support. Academic Press; 2018. p. 151-186. https://www.sciencedirect.com/science/article/pii/B9780128104910000059
Padalino MA, Bottio T, Tarzia V, Bortolussi G, Cerutti A, Vida VL, et al. HeartWare ventricular assist device as bridge to transplant in children and adolescents. Artif Organs. 2014;38(5):418-422. https://doi.org/10.1111/aor.12185
Conway J, Miera O, Adachi I, Maeda K, Eghtesady P, Henderson HT, et al. Kirk R; pediatric VAD investigators. Worldwide experience of a durable centrifugal flow pump in pediatric patients. Semin Thorac Cardiovasc Surg. 2018;30(3):327-335. https://doi.org/10.1053/j.semtcvs.2018.03.003
O'Connor MJ, Lorts A, Davies RR, Fynn-Thompson F, Joong A, Maeda K, et al. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: a multicenter registry analysis. J Heart Lung Transplant. 2020;39(6):573-579.
Deshpande SR, Slepian MJ, Alsoufi B. HeartWare HVAD market withdrawal and impact on the pediatric field. ASAIO J. 2021;67(8):825-826.
Van Puyvelde J, Jacobs S, Vlasselaers D, Meyns B. Heartmate 3 implantation in small patients: CT-guided chest diameter assessment. Interact Cardiovasc Thorac Surg. 2022 May 2;34(5):939-940.
Ponzoni M, Frigo CA, Castaldi B, Cerutti A, Di Salvo G, Vida LV, et al. Surgical strategies for the management of end-stage heart failure in infants and children: a 15-year experience with a patient-tailored approach. Artif Organs. 2021;45(12):1543-1553.
Lichtenstein KM, Tunuguntla HP, Peng DM, Buchholz H, Conway J. Pediatric ventricular assist device registries: update and perspectives in the era of miniaturized continuous-flow pumps. Ann Cardiothorac Surg. 2021;10(3):329-338.
Spigel ZA, Cho J, Adachi I. Current status of pediatric mechanical circulatory support. Curr Opin Organ Transplant. 2020;25(3):231-236.
Brancaccio G, Filippelli S, Michielon G, Iacobelli R, Alfieri S, Gandolfo F, et al. Ventricular assist devices as a bridge to heart transplantation or as destination therapy in pediatric patients. Transplant Proc. 2012;44(7):2007-2012.
Piperata A, Bottio T, Toscano G, Avesani M, Vianello A, Gerosa G. Is heart transplantation a real option in patients with Duchenne syndrome? Inferences from a case report. ESC Heart Fail. 2020;7(5):3198-3202.
O'Connor M, Lorts A, Daviers RR, Fynn-Thompson F, Joong A, Maeda k, et al. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: a multicenter registry analysis. J Heart Lung Transplant. 2020;39(6):573-579.
Adachi I, Burki S, Fraser CD. Current status of pediatric ventricular assist device support. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017;20:2-8.
Schroder JN, Milano CA. A tale of two centrifugal left ventricular assist devices. J Thorac Cardiovasc Surg. 2017;154(3):850-852.
Lamba HK, Kim M, Santiago A, Hudson S, Civitello AB, Nair AP, et al. Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022;25(1):16-23.
Wasilewski G, Kędziora A, Górkiewicz-Kot I, Stąpór M, Hymczak H, Wierzbicki K. How to improve the outcomes of LVAD implantation? Transplant Proc. 2022;54(4):1054-1057.
Goodwin K, Kluis A, Alexy T, John R, Voeller R. Neurological complications associated with left ventricular assist device therapy. Expert Rev Cardiovasc Ther. 2018;16(12):909-917.
Castrodeza J, Ortiz-Bautista C, Fernàndez-Avilès F. Continuous-flow left ventricular assist device: current knowledge, complications, and future directions. Cardiol J. 2022;29(2):293-304.